MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • 2022 International Congress

    Two cases of severe generalized dystonia in IRF2BPL and response to treatment

    M. Hull, M. Parnes (Houston, USA)

    Objective: We describe two patients who presented with progressive, generalized dystonia and associated neurodevelopmental regression in early childhood found to have pathogenic variants in IRF2BPL.…
  • 2022 International Congress

    Characterization of routine botulinum toxin (BoNT) therapy and patient population in cervical dystonia

    B. Waeschle, H. Stark, P. Albrecht (Düsseldorf, Germany)

    Objective: We conducted a survey to characterize real-world treatment of CD patients with focus on treatment duration, clinical parameters and awareness of clinical resistance as…
  • 2022 International Congress

    DBS for a patient with KMT2B-SHANK2 related dystonia

    L. Pan, G. Riboldi, A. Mogilner, C. Toro, S. Frucht (New York, USA)

    Objective: Describe a case of deep brain stimulation (DBS) outcome for a patient with pathogenic variants of Shank2 and KMT2B genes. Background: Prior reports have…
  • 2022 International Congress

    Assessment of mood symptoms and influence on disease in cervical dystonia

    S. Rafee, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

    Objective: To compare mood symptom rating scales and influence of anxiety and depressive symptoms on motor severity and aspects of quality of life. Background: Cervical…
  • 2022 International Congress

    Transcranial magnetic resonance-guided focused ultrasound in Lance-Adams syndrome

    R. Galimova, YU. Sidorova, G. Akhmadeeva, O. Kachemaeva, D. Krekotin, I. Buzaev, N. Muhamadeeva (Ufa, Russian Federation)

    Objective: The objective is to present the first reported case of a patient with post-hypoxic myoclonus (PHM) who underwent noninvasive MR-guided Focused Ultrasound Treatment (MRgFUS).…
  • 2022 International Congress

    Internal globus pallidus deep brain stimulation in ACTB-related deafness-dystonia

    D. Macias-Garcia, S. Jesús, A. Adarmes-Gomez, L. Muñoz-Delgado, F. Carrillo, P. Mir (Seville, Spain)

    Objective: To describe the response to deep brain stimulation (DBS) in a patient with ACTB-related deafness-dystonia syndrome with three years of follow-up and to review…
  • 2022 International Congress

    SETTING UP A PEDIATRIC DEEP BRAIN STIMULATION UNIT

    J. Ferrero-Turrión, A. Salazar-Villacorta, A. Bescos, G. Español, L. Ispierto, R. Alvarez, M. Tardáguila, J. Muñoz, L. Ventura-Expósito, B. Pérez-Dueñas (Barcelona, Spain)

    Objective: Describe our 2-year experience establishing a pediatric deep brain stimulation (pDBS) service in a tertiary hospital and report our outcomes. Background: DBS is a…
  • 2022 International Congress

    Evaluation of Atrophy after Botulinum Toxin injection for Cervical Dystonia by MRI

    M. Salari, M. Etemadifar, S. Parvizi (Tehran, Islamic Republic of Iran)

    Objective: Cervical Dystonia (CD) is the most common form of focal dystonia involving the muscles of the neck and sometimes the shoulders. 1 There are several categories…
  • 2022 International Congress

    Impact of botulinum toxin treatment on gait in focal dystonia

    J. Cuinat, B. Debu, P. Pelissier, A. Castrioto, S. Meoni, S. Potel, V. Fraix, E. Moro (Grenoble, France)

    Objective: To study the effects of botulinum neurotoxin (BTX) treatment on gait characteristics in patients with blepharospasm and cervical dystonia. Background: The impact of focal…
  • 2022 International Congress

    Early intervention with deep brain stimulation for children with ε-sarcoglycan myoclonus dystonia

    A. Salazar, M. Correa-Vela, M. González, L. Ispierto, J. Ferrero-Turrion, G. Español, A. Bescós, M. Tardáguila, B. Pérez-Dueñas (Barcelona, Spain)

    Objective: To evaluate the efficacy and safety of Globus Pallidus Internus DBS (GPi-DBS) in early stages of disease course. Background: SGCE-related myoclonus-dystonia (SGCE-MD) is considered…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 43
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley